Literature DB >> 16365529

Inhibitory effect of RNAi on Japanese encephalitis virus replication in vitro and in vivo.

Manabu Murakami1, Takahide Ota, Soichi Nukuzuma, Tsutomu Takegami.   

Abstract

Flaviviruses include many insect-mediated small viruses and still cause serious problems in the world. In humans, JEV can cause acute meningioencephalomyelitis, resulting in fatality rates of 5 to 40%. RNA-interference (RNAi) as an antiviral mechanism was originally discovered in plants and then found in the specific suppression of gene expression of other organisms such as Caenorhabditis elegans, Drosophila and vertebrates. As JEV is an RNA virus, RNAi could be a reasonable approach for therapeutic purposes to use against Japanese encephalitis. In this study, we examined the effect of RNAi on JEV replication. Viral reproduction in Vero cells was decreased to 7.2% and 39.0% of control by the transfection of small interference RNAs, JCR and JN3R at 250 n M, respectively. Under the transfection of 5 microg/ml pJRi which produces stem-loop RNAi, viral reproduction was decreased to about 10% of control. Western blot analysis indicated that RNAi inhibited the translation level. We used pJRi in the animal experiment. After the inoculation of viruses at 5 x 10(3) PFU, pJRi at 1.0 and 5.0 microg/g was injected into mice i.p. JEV-infected control mice (n=5) died within 15 days. pJRi (1.0 or 5.0 microg/g)-medicated mice survived 40 or 80% at 15 days. The data clearly indicate that pJRi has highly potent inhibitory activity against JEV replication in vivo. The results in vivo and in vitro provide evidence that JEV replication was efficiently inhibited by RNAi and RNAis could be used as an antiviral drug against JEV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365529     DOI: 10.1111/j.1348-0421.2005.tb03701.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  11 in total

1.  RNA interference inhibits yellow fever virus replication in vitro and in vivo.

Authors:  Carolina C Pacca; Adriana A Severino; Adriano Mondini; Paula Rahal; Solange G P D'avila; José Antonio Cordeiro; Mara Correa Lelles Nogueira; Roberta V M Bronzoni; Maurício L Nogueira
Journal:  Virus Genes       Date:  2009-01-25       Impact factor: 2.332

2.  Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence.

Authors:  David A Stein; Stuart T Perry; Michael D Buck; Christopher S Oehmen; Matthew A Fischer; Elizabeth Poore; Jessica L Smith; Alissa M Lancaster; Alec J Hirsch; Mark K Slifka; Jay A Nelson; Sujan Shresta; Klaus Früh
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

3.  Identification and characterization of inhibitors of West Nile virus.

Authors:  Francesc Puig-Basagoiti; Min Qing; Hongping Dong; Bo Zhang; Gang Zou; Zhiming Yuan; Pei-Yong Shi
Journal:  Antiviral Res       Date:  2009-04-01       Impact factor: 5.970

4.  Antiviral and neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis.

Authors:  Arshed Nazmi; Kallol Dutta; Anirban Basu
Journal:  PLoS Negl Trop Dis       Date:  2010-11-23

5.  Broad-spectrum antiviral activity of RNA interference against four genotypes of Japanese encephalitis virus based on single microRNA polycistrons.

Authors:  Zhiqiang Wu; Ying Xue; Bei Wang; Jiang Du; Qi Jin
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

6.  P247 and p523: two in vivo-expressed megalocytivirus proteins that induce protective immunity and are essential to viral infection.

Authors:  Jian Zhang; Bao Cun Zhang; Li Sun
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

7.  Sphingomyelin generated by sphingomyelin synthase 1 is involved in attachment and infection with Japanese encephalitis virus.

Authors:  Makoto Taniguchi; Takafumi Tasaki; Hideaki Ninomiya; Yoshibumi Ueda; Koh-Ichi Kuremoto; Susumu Mitsutake; Yasuyuki Igarashi; Toshiro Okazaki; Tsutomu Takegami
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

8.  siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA.

Authors:  Zhao-ling Qin; Ping Zhao; Ming-mei Cao; Zhong-tian Qi
Journal:  J Virol Methods       Date:  2007-06-27       Impact factor: 2.014

9.  SiRNA inhibits replication of Langat virus, a member of the tick-borne encephalitis virus complex in organotypic rat brain slices.

Authors:  Carola Maffioli; Denis Grandgirard; Stephen L Leib; Olivier Engler
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

10.  Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus.

Authors:  Deepti Parashar; Mandar S Paingankar; Satyendra Kumar; Mangesh D Gokhale; A B Sudeep; Sapana B Shinde; V A Arankalle
Journal:  PLoS Negl Trop Dis       Date:  2013-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.